Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,362 INR | -2.15% | +6.04% | +20.32% |
05-14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
05-10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.32% | 997M | |
+49.07% | 780B | |
+41.76% | 627B | |
+19.56% | 334B | |
+7.47% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.57% | 161B | |
-3.87% | 159B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Neuland Laboratories Limited Approves the Resignation of Anil Kumar as Chief Financial Officer, with Effect from February 28, 2017